PROGNOSTIC FACTORS FOR LOCAL RECURRENCE IN BREAST CONSERVATION THERAPY - RESIDUAL CANCERS AFTER LUMPECTOMY

被引:4
作者
FUKUTOMI, T
YAMAMOTO, H
NANASAWA, T
ITABASHI, M
HIROTA, T
机构
[1] The Department of Surgery, National Cancer Center Hospital, Tokyo, 104, 1-1, 5-chome, Tsukiji, Chuo-ku
[2] The Department of Pathology, National Cancer Center Hospital, Tokyo, 104, 1-1, 5-chome, Tsukiji, Chuo-ku
来源
SURGERY TODAY-THE JAPANESE JOURNAL OF SURGERY | 1993年 / 23卷 / 05期
关键词
LOCAL RECURRENCE; RESIDUAL CANCER; PROGNOSTIC FACTOR; BREAST CONSERVATION THERAPY;
D O I
10.1007/BF00309497
中图分类号
R61 [外科手术学];
学科分类号
摘要
In order to evaluate the local residual cancer following breast conservation therapy (BCT) with lumpectomy, we investigated the relationships between residual cancer and age, tumor location, tumor diameter (T), mammography findings, nipple discharge findings, histopathological type, lymphatic and/or vascular invasion by tumor cells, histological grading, histological lymph node metastases (n), and estrogen receptor (ER) status, in 1494 patients with breast cancer that involved diagnostic excisional biopsy. Residual cancers were found in 581 of 1448 (40%) mastectomy specimens, after 46 (3.1%) with multicentricity had been excluded. No correlation was observed between residual cancer and age, histological grading, and ER. However, residual cancer rates were significantly higher in patients with: (1) tumor diameters of 3.1 cm or larger; (2) tumors beneath or in the vicinity of the nipple-areola; () malignant calcifications noted in mammography findings; (4) serous or bloody nipple discharge, particularly with positive cytologic findings; (5) papillotubular carcinoma diagnosed by biopsy, (6) lymphatic invasion by tumor cells; or (7) a high degree (n greater-than-or-equal-to 4) of lymph node metastases. The above seven clinicopathologic factors are thus considered useful prognostic indicators for local recurrence in BCT with lumpectomy.
引用
收藏
页码:402 / 406
页数:5
相关论文
共 12 条
[1]  
Fukutomi T., Yamamoto H., Nanasawa T., Itabashi M., Ogino H., Tsukiyama I., Hirota T., Histological and biological evaluation of preoperative radiotherapy on T1N0 breast carcinomas, Nippon Geka Gakkai Zasshi (J Jpn Surg Soc), 93, pp. 183-188, (1992)
[2]  
Kasumi F., Iwase T., Yoshimoto M., Watanabe S., Breast conservative management in Japan — from the surgeon's point of view, Nyugan no Rinsho (Jpn J Breast Cancer), 4, pp. 482-488, (1989)
[3]  
Consensus on treatment of early stage breast cancer: Less surgery, more research, J Natl Cancer Inst, 82, pp. 1180-1181, (1990)
[4]  
Elston C.W., Grading of invasive carcinoma of the breast, Diagnostic histopathology of the breast, pp. 300-311, (1987)
[5]  
Bonadonna G., Veronesi U., Brambilla C., Ferrari L., Luini A., Grecco M., Bartoli C., De Yoldi G., Zucali R., Rilke F., Andoreola S., Silvestrini R., Di Fronzo G., Valagussa S., Primary chemotherapy to avoid mastectomy in tumors with diameters of 3 cm or more, J Natl Cancer Inst, 82, pp. 1539-1545, (1990)
[6]  
Haffty B.G., Fischer D., Rose M., Beinfield M., McKhann C., Prognostic factors for local recurrence in the conservatively treated breast cancer patient: A cautious interpretation of the data, J Clin Oncol, 9, pp. 997-1003, (1991)
[7]  
Gallagher W.J., Koerner F.C., Wood W.C., Treatment of intraductal carcinoma with limited surgery: Long-term follow-up, J Clin Oncol, 7, pp. 376-380, (1989)
[8]  
Silverstein M.J., Waisman J.R., Gierson E.D., Radiation therapy for intraductal carcinoma. Is it an equal alternative?, Arch Surg, 126, pp. 424-428, (1991)
[9]  
Holland R., Connolly J.L., Gelmam R., Muravunac M., Hendriks J.H.C.L., Verbeek A.L.M., Schnitt S.J., Silver B., Boyages J., The presence of an extensive intraductal component following a limited excision correlates with prominent residual disease in the remainder of the breast, J Clin Oncol, 8, pp. 113-118, (1990)
[10]  
Kurtz J.M., Jacquemier J., Amalric R., Brandone H., Ayme Y., Hans D., Bressac C., Spitalier J.M., Breast-conserving therapy for macroscopically multiple cancers, Ann Surg, 212, pp. 38-44, (1990)